Molecular Partners AG (MOLN)
6.12
+0.76
(+14.18%)
USD |
NASDAQ |
Nov 01, 16:00
6.15
+0.03
(+0.49%)
After-Hours: 20:00
Molecular Partners Price: 6.12 for Nov. 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 6.21 | 6.24 | 6.01 | 6.12 | 7813.00 |
Oct 31, 2024 | 6.004 | 6.004 | 5.30 | 5.36 | 21433.00 |
Oct 30, 2024 | 6.17 | 6.25 | 6.08 | 6.15 | 6584.00 |
Oct 29, 2024 | 6.63 | 6.63 | 6.11 | 6.20 | 19525.00 |
Oct 28, 2024 | 6.57 | 6.57 | 6.05 | 6.46 | 38836.00 |
Oct 25, 2024 | 6.53 | 6.90 | 6.40 | 6.49 | 42253.00 |
Oct 24, 2024 | 6.24 | 6.24 | 5.75 | 6.02 | 6746.00 |
Oct 23, 2024 | 6.19 | 6.264 | 5.59 | 5.669 | 17996.00 |
Oct 22, 2024 | 7.30 | 7.60 | 6.23 | 6.57 | 109956.0 |
Oct 21, 2024 | 6.08 | 7.250 | 5.87 | 6.78 | 399676.0 |
Oct 18, 2024 | 5.15 | 5.344 | 4.87 | 4.87 | 17413.00 |
Oct 17, 2024 | 4.91 | 4.99 | 4.91 | 4.98 | 2440.00 |
Oct 16, 2024 | 4.75 | 4.979 | 4.70 | 4.95 | 6432.00 |
Oct 15, 2024 | 4.83 | 4.95 | 4.71 | 4.95 | 21057.00 |
Oct 14, 2024 | 4.83 | 4.97 | 4.75 | 4.75 | 2593.00 |
Oct 11, 2024 | 4.75 | 4.75 | 4.75 | 4.75 | 0.000 |
Oct 10, 2024 | 5.09 | 5.35 | 4.73 | 4.75 | 8219.00 |
Oct 09, 2024 | 4.906 | 4.906 | 4.906 | 4.906 | 0.000 |
Oct 08, 2024 | 4.825 | 5.35 | 4.75 | 4.906 | 2319.00 |
Oct 07, 2024 | 4.86 | 5.32 | 4.40 | 4.76 | 47698.00 |
Oct 04, 2024 | 4.60 | 5.02 | 4.60 | 5.02 | 730.00 |
Oct 03, 2024 | 4.55 | 4.75 | 4.525 | 4.58 | 10069.00 |
Oct 02, 2024 | 4.603 | 4.77 | 4.37 | 4.63 | 11952.00 |
Oct 01, 2024 | 4.75 | 5.00 | 4.69 | 4.790 | 6340.00 |
Sep 30, 2024 | 4.756 | 5.135 | 4.756 | 5.087 | 11133.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.32
Minimum
Apr 19 2024
31.89
Maximum
Jan 14 2022
9.418
Average
6.46
Median
Jul 19 2022
Price Benchmarks
AC Immune SA | 3.00 |
CRISPR Therapeutics AG | 50.76 |
Addex Therapeutics Ltd | 10.70 |
NLS Pharmaceutics Ltd | 3.60 |
MoonLake Immunotherapeutics | 46.76 |
Price Related Metrics
PS Ratio | 22.67 |
Price to Book Value | 1.174 |
Earnings Yield | -32.21% |
Market Cap | 203.08M |